|
19
|
118
|
7dtgA |
Crystal structure of lamin b1 ig-like domain from human |
|
44
|
112
|
7oetAAA |
C-terminal bromodomain of human brd2 with 1,5-dimethyl-n-(2-(methylamino)-2-oxo-1-(tetrahydro-2h-pyran-4-yl)ethyl)-6-oxo-n-(2-phenyl-2-(pyridin-2-yl)ethyl)-1,6-dihydropyridine-3-carboxamide |
|
57
|
133
|
7m98A |
Atad2 bromodomain complexed with histone h4k5ac (res 1-10) ligand |
|
26
|
90
|
7d69A |
Cryo-em structure of the nucleosome containing giardia histones |
|
23
|
95
|
7d69C |
Cryo-em structure of the nucleosome containing giardia histones |
|
33
|
96
|
7d69D |
Cryo-em structure of the nucleosome containing giardia histones |
|
24
|
78
|
7d69B |
Cryo-em structure of the nucleosome containing giardia histones |
|
27
|
131
|
7crgA |
Beta-strand-mediated dimeric formation of the extended ig-like domains of human lamin a/c |
|
81
|
414
|
7cv6B |
Rna methyltransferase mettl4 |
|
97
|
413
|
7cv7A |
Rna methyltransferase mettl4 |
|
91
|
412
|
7cvaA |
Rna methyltransferase mettl4 |
|
99
|
414
|
7cv8A |
Rna methyltransferase mettl4 |
|
102
|
413
|
7cv9A |
Rna methyltransferase mettl4 |
|
34
|
97
|
7ohcD |
Cryo-em structure of nucleosome core particle composed of the widom 601 dna sequence |
|
44
|
111
|
7ogyAAA |
C-terminal bromodomain of human brd2 with 1-benzyl-n5-cyclopropyl-n3-methyl-1h-pyrazole-3,5-dicarboxamide |
|
28
|
109
|
7ohcC |
Cryo-em structure of nucleosome core particle composed of the widom 601 dna sequence |
|
31
|
97
|
7ohcA |
Cryo-em structure of nucleosome core particle composed of the widom 601 dna sequence |
|
26
|
82
|
7ohcB |
Cryo-em structure of nucleosome core particle composed of the widom 601 dna sequence |
|
41
|
111
|
7oeoAAA |
C-terminal bromodomain of human brd4 n-(2,2-diphenylethyl)-4-methoxy-3,5-dimethyl-n-(2-(methylamino)-2-oxoethyl)benzamide |
|
44
|
113
|
7oepAAA |
C-terminal bromodomain of human brd2 with 5-(1-(1,3-dimethoxypropan-2-yl)-5-morpholino-1h-benzo[d]imidazol-2-yl)-1,3-dimethylpyridin-2(1h)-one |
|
44
|
110
|
7oerAAA |
C-terminal bromodomain of human brd2 with n-(2,2-diphenylethyl)-1,5-dimethyl-n-(2-(methylamino)-2-oxoethyl)-6-oxo-1,6-dihydropyridine-3-carboxamide |
|
42
|
113
|
7oe4AAA |
C-terminal bromodomain of human brd2 with n-methyl-4-propionyl-1h-pyrrole-2-carboxamide |
|
46
|
112
|
7oesAAA |
C-terminal bromodomain of human brd2 with 1,5-dimethyl-n-(2-(methylamino)-2-oxoethyl)-6-oxo-n-(2-phenylpropyl)-1,6-dihydropyridine-3-carboxamide |
|
42
|
110
|
7oe5AAA |
C-terminal bromodomain of human brd2 with n5-hydroxycyclohexyl-n3-methyl-1-phenylethyl-1h-pyrazole-3,5-dicarboxamide |
|
43
|
111
|
7oe6AAA |
C-terminal bromodomain of human brd2 with n4-hydroxycyclohexyl-n2-methyl-5-phenylethyl-furan-2,4-dicarboxamide |
|
41
|
110
|
7oe9A |
C-terminal bromodomain of human brd2 with rac-n5-((1r,5s)-3-oxabicyclo[3.1.0]hexan-6-yl)-n7,3-dimethyl-3-phenyl-2,3-dihydrobenzofuran-5,7-dicarboxamide |
|
44
|
112
|
7oe8A |
C-terminal bromodomain of human brd2 with n5-((1r,5s,6r)-3-oxabicyclo[3.1.0]hexan-6-yl)-3-(1h-indol-4-yl)-n7-methyl-2,3-dihydrobenzofuran-5,7-dicarboxamide |
|
42
|
113
|
7nq3AAA |
C-terminal bromodomain of human brd2 with n4-((1r,5s,6r)-3-oxabicyclo[3.1.0]hexan-6-yl)-6-((s)-methoxy(phenyl)methyl)-n2-methylpyridine-2,4-dicarboxamide |
|
42
|
113
|
7nq1AAA |
C-terminal bromodomain of human brd2 with 6-((s)-hydroxy(phenyl)methyl)-n2-methyl-n4-((1s,2s)-2-methylcyclopropyl)pyridine-2,4-dicarboxamide |
|
42
|
113
|
7nq0AAA |
C-terminal bromodomain of human brd2 with oxabicyclo(hexan-6-yl)-n2-methyl-6-((s)-1-phenylethyl)pyridine-2,4-dicarboxamide |
|
45
|
112
|
7npzAAA |
C-terminal bromodomain of human brd2 with (r)-n5-cyclopropyl-n3-methyl-2-oxo-1-(1-phenylethyl)-1,2-dihydropyridine-3,5-dicarboxamide |
|
41
|
112
|
7nq2AAA |
C-terminal bromodomain of human brd2 with (s)-n4-cyclopropyl-n2-methyl-6-(1-phenylethyl)pyridine-2,4-dicarboxamide |
|
30
|
124
|
7nqaC |
Complex of nucleoporin-98 and nanobody ms98-27 solved at 1.85a resolution |
|
43
|
111
|
7npyAAA |
C-terminal bromodomain of human brd2 with 6-benzyl-n2-methyl-n4-((1s,2s)-2-methylcyclopropyl)pyridine-2,4-dicarboxamide |
|
42
|
152
|
7nqaA |
Complex of nucleoporin-98 and nanobody ms98-27 solved at 1.85a resolution |
|
2
|
53
|
7bdxE |
Armadillo domain of hsf2bp in complex with brca2 peptide |
|
75
|
211
|
7bdxA |
Armadillo domain of hsf2bp in complex with brca2 peptide |
|
106
|
374
|
7ewqA |
Structure of mumps virus nucleocapsid ring |
|
80
|
354
|
7e8iK |
Structural insight into brca1-bard1 complex recruitment to damaged chromatin |
|
26
|
96
|
7e8iA |
Structural insight into brca1-bard1 complex recruitment to damaged chromatin |
|
12
|
76
|
7e8iL |
Structural insight into brca1-bard1 complex recruitment to damaged chromatin |
|
23
|
89
|
7e8iB |
Structural insight into brca1-bard1 complex recruitment to damaged chromatin |
|
27
|
108
|
7e8iC |
Structural insight into brca1-bard1 complex recruitment to damaged chromatin |
|
30
|
92
|
7e8iD |
Structural insight into brca1-bard1 complex recruitment to damaged chromatin |
|
74
|
192
|
7dlxA |
Crystal structure of h2am4>z-h2b |
|
99
|
242
|
7necA |
Ror(gamma)t ligand binding domain in complex with allosteric ligand fm217 |
|
95
|
242
|
7np6A |
Ror(gamma)t ligand binding domain in complex with allosteric ligand fm257 |
|
91
|
240
|
7npcA |
Ror(gamma)t ligand binding domain in complex with allosteric ligand fm156 |
|
97
|
242
|
7np5A |
Ror(gamma)t ligand binding domain in complex with allosteric ligand fm216 |
|
51
|
124
|
7m97A |
Crystal structure of the bromodomain from plasmodium falciparum bromodomain protein 1 |
